Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
SymbolNYSE:EVH
CUSIPN/A
Phone571-389-6000
Debt
Debt-to-Equity Ratio0.12
Current Ratio2.88
Quick Ratio2.88
Price-To-Earnings
Trailing P/E Ratio-33.14
Forward P/E Ratio-69.55
P/E GrowthN/A
Sales & Book Value
Annual Sales$434.95 million
Price / Sales4.11
Cash FlowN/A
Price / CashN/A
Book Value$13.52 per share
Price / Book1.70
Profitability
EPS (Most Recent Fiscal Year)($0.70)
Net Income$-60,660,000.00
Net Margins-12.11%
Return on Equity-2.16%
Return on Assets-1.73%
Miscellaneous
Employees2,600
Outstanding Shares77,940,000
Market Cap$1,761.56
Evolent Health (NYSE:EVH) Frequently Asked Questions
What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
How were Evolent Health's earnings last quarter?
Evolent Health Inc (NYSE:EVH) announced its quarterly earnings results on Wednesday, May, 9th. The technology company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.06. The technology company earned $139.70 million during the quarter, compared to analyst estimates of $140.89 million. Evolent Health had a negative return on equity of 2.16% and a negative net margin of 12.11%. The firm's revenue was up 31.5% on a year-over-year basis. During the same quarter last year, the firm posted ($0.14) earnings per share. View Evolent Health's Earnings History.
What price target have analysts set for EVH?
14 Wall Street analysts have issued 1 year price targets for Evolent Health's stock. Their predictions range from $20.00 to $31.00. On average, they expect Evolent Health's stock price to reach $26.5455 in the next year. This suggests a possible upside of 15.7% from the stock's current price. View Analyst Ratings for Evolent Health.
What is the consensus analysts' recommendation for Evolent Health?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
What are Wall Street analysts saying about Evolent Health stock?
Here are some recent quotes from research analysts about Evolent Health stock:
- 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (7/10/2018)
- 2. Cantor Fitzgerald analysts commented, "Health plan acquisitions. Over the past few months, EVH has announced two small health plan acquisitions that should help to grow its platform and operations revenue and add a new line of business. The acquisition of Premier in Dayton, OH, is somewhat more concerning for investors as the regulatory filings show that the plan is in a loss position. However, many provider-owned health plans typically show losses in regulatory filings. The company is expecting to receive better pricing from Premier and that it is not considering additional health plan acquisitions, at least in the near term. However, it will continue to use capital to align the company with customers. Note, our estimates do not yet reflect the health plan acquisitions." (12/3/2017)
Who are some of Evolent Health's key competitors?
Who are Evolent Health's key executives?
Evolent Health's management team includes the folowing people:
- Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 51)
- Mr. Seth Blackley, Co-Founder, Pres & Director (Age 39)
- Mr. Thomas Peterson III, Co-Founder & COO (Age 48)
- Mr. Nicholas McGrane, Chief Financial Officer (Age 50)
- Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 42)
When did Evolent Health IPO?
(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.
Has Evolent Health been receiving favorable news coverage?
Press coverage about EVH stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Evolent Health earned a media sentiment score of 0.01 on Accern's scale. They also gave media stories about the technology company an impact score of 46.10 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are Evolent Health's major shareholders?
Evolent Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (4.54%), Peregrine Capital Management LLC (1.22%), Baillie Gifford & Co. (1.11%), Lenox Wealth Advisors LLC (0.09%), Campbell & CO Investment Adviser LLC (0.02%) and Fox Run Management L.L.C. (0.01%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health.
Which major investors are selling Evolent Health stock?
EVH stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Seth Blackley, Steve Wigginton, Thomas Peterson III and Unitedhealth Group Inc. View Insider Buying and Selling for Evolent Health.
Which major investors are buying Evolent Health stock?
EVH stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Riverbridge Partners LLC, Lenox Wealth Advisors LLC, Campbell & CO Investment Adviser LLC and Fox Run Management L.L.C.. View Insider Buying and Selling for Evolent Health.
How do I buy shares of Evolent Health?
Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Evolent Health's stock price today?
One share of EVH stock can currently be purchased for approximately $22.95.
How big of a company is Evolent Health?
Evolent Health has a market capitalization of $1.76 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.
How can I contact Evolent Health?
Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.
MarketBeat Community Rating for Evolent Health (NYSE EVH)
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
